JPH10139676A - Antiallergic composition for skin lotion - Google Patents

Antiallergic composition for skin lotion

Info

Publication number
JPH10139676A
JPH10139676A JP8332642A JP33264296A JPH10139676A JP H10139676 A JPH10139676 A JP H10139676A JP 8332642 A JP8332642 A JP 8332642A JP 33264296 A JP33264296 A JP 33264296A JP H10139676 A JPH10139676 A JP H10139676A
Authority
JP
Japan
Prior art keywords
extract
skin
composition
antiallergic
ebine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8332642A
Other languages
Japanese (ja)
Other versions
JP3702307B2 (en
Inventor
Manabu Nomura
学 野邨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP33264296A priority Critical patent/JP3702307B2/en
Publication of JPH10139676A publication Critical patent/JPH10139676A/en
Application granted granted Critical
Publication of JP3702307B2 publication Critical patent/JP3702307B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain an antiallergic composition for skin lotion, effective to an allergic disease, especially atopic dermatitis and containing nontoxic extract of a plant. SOLUTION: This composition includes an extract extracted from whole plant such as a leaf, a flower, a stem and a root of Calanthe belonging to genus calanthe of orchid family by hydrated ethyl alcohol as an effective ingredient. The addition of sodium pantothenate, nicotinamide, tocopherol acetate, ascorbic acid, biotin, vitamins such as vitamin B6 , oils of animals and plants such as germ oil and oil of a horse, glycolic acid, sodium chloride, etc., can synergistically improve the effect. The composition has activities for skin care in addition to the antiallergic activities, and has fragrance when only the extract from the flower of the Calanthe is used. The composition is used as a skin lotion, a lotion, an emulsion, a cream, an ointment, etc., and further as a bathing agent.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、植物抽出物を有効
成分として含む新規な抗アレルギー性皮膚外用組成物、
特にアトピー性疾患治療に適した抗アレルギー性皮膚外
用組成物に関するものである。
TECHNICAL FIELD The present invention relates to a novel antiallergic external skin composition containing a plant extract as an active ingredient,
Particularly, the present invention relates to an antiallergic skin external composition suitable for treating atopic diseases.

【0002】[0002]

【従来の技術】これまで、アトピー性皮膚炎のようなア
レルギー疾患に対する治療法は、抗ヒスタミン剤の内
服、免疫グロプリン製剤の皮下注射、ステロイド軟膏の
ような外用薬が用いられてきた。しかしながら、これら
の医薬療法は顕著な効果の反面副作用が強く長期の治療
には不向きであった。一方、誰もが日常いつでも手軽に
利用できる抗アレルギー性の皮膚外用組成物、浴用剤、
化粧料等も、広く提案されている。その多くは有効成分
として植物抽出物を用いている。たとえば、ハイビスカ
スの葉及びアロエの葉肉の汁を用いたもの(特開平5−
306210号)、アマチャ抽出物を用いたもの(特開
平5−43445号)、シソ科植物の抽出物を用いたも
の(特開平6−293652号)、ビワの葉の抽出物を
用いたもの(特開平8−73314号)、ヒユ科植物の
エキスを用いたもの(特開平8−99889号)など、
多数知られている。
2. Description of the Related Art Heretofore, as a treatment for allergic diseases such as atopic dermatitis, oral use of antihistamines, subcutaneous injection of immunoglobulin preparations, and external preparations such as steroid ointments have been used. However, these medicinal therapies have remarkable effects, but have strong side effects and are not suitable for long-term treatment. On the other hand, anti-allergic skin external composition, bath agent, which can be easily used at any time by anyone
Cosmetics and the like have been widely proposed. Many use plant extracts as active ingredients. For example, one using hibiscus leaf and aloe leaf juice (Japanese Unexamined Patent Publication No.
No. 306210), an extract using an amateur extract (JP-A-5-43445), an extract using a Labiatae plant (JP-A-6-293652), and an extract using a loquat leaf extract ( Japanese Patent Application Laid-Open No. 8-73314), those using extracts of Amaranthus (Japanese Patent Application Laid-Open No. 8-99889), and the like.
Many are known.

【0003】これらの植物由来の抗アレルギー性抽出物
は、天然物由来でも単一の単離化合物とは異なり、いず
れもその生理及び薬理作用は複雑で比較的マイルドなの
が特徴であり、幼児のような敏感な皮膚のアトピー性疾
患の日常のケアに、長期にわたって利用しやすい利点が
ある。また植物抽出物の場合、原料植物の種類によっ
て、その生理及び薬理活性も微妙に異なるのが普通であ
り、皮膚の美容効果を奏するものもある。したがって、
その剤形もローション、乳液、クリーム、パック、軟
膏、化粧水、浴用剤など多様である。
[0003] These plant-derived antiallergic extracts are different from a single isolated compound even when derived from a natural product, and are characterized in that their physiological and pharmacological actions are complicated and relatively mild. The daily care of such sensitive skin atopic diseases has the advantage of being accessible over the long term. In the case of a plant extract, the physiological and pharmacological activities thereof are usually slightly different depending on the type of the raw material plant, and some of them have a cosmetic effect on the skin. Therefore,
The dosage forms also vary, such as lotions, emulsions, creams, packs, ointments, lotions, bath preparations, and the like.

【0004】[0004]

【発明が解決しようとする課題】近年は、多くの抗アレ
ルギー性組成物が開発されつつあるにもかかわらず、食
生活の変化、環境破壊をはじめ、医薬品、化粧品、ある
いはその他の身のまわりの合成樹脂、繊維、食物への添
加剤など多数の化学薬品との接触から、食餌アレルギ
ー、花粉アレルギー、薬剤アレルギー、接触アレルギー
等のアレルギー症状を訴える人はなお増加の傾向にあ
る。
In recent years, despite the development of many anti-allergic compositions, changes in dietary habits, environmental destruction, pharmaceuticals, cosmetics, and other personal items have been reported. People who complain of allergic symptoms such as dietary allergy, pollen allergy, drug allergy, contact allergy and the like due to contact with many chemicals such as synthetic resins, fibers and additives to foods are still increasing.

【0005】本発明者は、上記のごとき現況に鑑み、各
種の植物、特にラン科植物につき鋭意研究の結果、驚く
べきことに、ある属のラン科植物抽出液がアトピー性皮
膚炎のようなアレルギー性疾患に対し顕著な効果があ
り、しかも毒性がないことを見いだし、本発明にいたっ
た。
In view of the above situation, the present inventors have conducted intensive studies on various plants, particularly orchids, and surprisingly found that an extract of a certain genus orchid plant has an atopic dermatitis such as atopic dermatitis. The present inventors have found that the compound has a remarkable effect on allergic diseases and has no toxicity.

【0006】本発明は、かかる知見に基づくもので、抗
アレルギー効果があり且つ無毒性の皮膚外用組成物を提
供することを目的としている。
[0006] The present invention is based on this finding and has an object to provide a non-toxic external skin composition having an antiallergic effect.

【0007】[0007]

【課題を解決するための手段】前記目的を達成した本発
明の抗アレルギー性皮膚外用組成物は、ラン科植物のエ
ビネ属に属するエビネの少なくとも1種からの抽出物を
有効成分として含むことを特徴としている。
The antiallergic skin external composition of the present invention, which has achieved the above object, comprises, as an active ingredient, an extract from at least one species of Ebine belonging to the genus Ebine of the orchid family. Features.

【0008】抽出物を有効成分とするものとしては、各
種の抗アレルギー性組成物、アトピー性皮膚炎治療剤、
抗アレルギー性浴用剤、抗アレルギー化粧料として有用
である。また、抗アレルギー以外の皮膚外用組成物、例
えば痔疾治療剤、草まけ、漆まけ、虫まけ治療剤、床ず
れ治療剤、水虫治療剤、火傷治療剤においても有効であ
る。また搾汁した原液そのまま、あるいは適宜水で希釈
したものを、口腔用組成物、特に歯槽膿漏、口内炎治療
用うがい液等に使用すると著効がある。乳酸菌に対して
は、選択的に増殖抑制効果がある。
[0008] The extract containing the active ingredient as an active ingredient includes various antiallergic compositions, therapeutic agents for atopic dermatitis,
It is useful as an antiallergic bath agent and antiallergic cosmetic. It is also effective in skin external compositions other than anti-allergic agents, for example, hemorrhoid treating agents, weeding, lacquering, insect repelling agents, bedsores, athlete's foot, and burns. In addition, it is extremely effective to use the undiluted solution as it is or diluted appropriately with water as an oral composition, especially a gargle for the treatment of alveolar pyorrhea and stomatitis. Lactic acid bacteria have a selective growth inhibitory effect.

【0009】[0009]

【発明の実施の形態】本発明において、ラン科植物のエ
ビネ属のエビネとしては、次のものを例示できる。 (1).ジエビネ型:ジエビネ(C.discolo
r)、キエビネ(C.sieboldii)、キリシマ
エビネ(C.aristulifera)、アマミエビ
ネ(C.amamiana)、ニオイエビネ(C.iz
u−insularis)、サルメンエビネ(C.tr
icarinata)、トクノシマエビネ(C.tok
unoshimaensis)、アリサンエビネ(C.
arisanensis)、ホソバナエビネ(C.gr
aciliflora)、ヒマラヤニオイエビネ(C.
plantaginea)、クロロレウカ(C.chl
oroleuca)、トガリバエビネ(C.cauda
tilabella)。 (2).スズフリエビネ型:スズフリエビネ(C.li
ukiuensis)、タマザキエビネ(C.dens
iflora)、プルクラ(C.pulchra)。 (3).タガネラン型:タガネラン(C.bungoa
na)、ホワイテアナ(C.whiteana)。 (4).サクラジマエビネ型:サクラジマエビネ(C.
oblanceolata)、マンニイ(C.mann
i)。 (5).キソエビネ型:キソエビネ(C.schlec
hteri)、アルピナ(C.alpina)。 (6).キンセイラン型:キンセイラン(C.nipp
onica)。 (7).ヒロハノカラン型:ヒロハノカラン(C.ja
ponica)。 (8).アサヒエビネ型:アサヒエビネ(C.hatt
orii)。 (9).ナツエビネ型:ナツエビネ(C.reflex
a)。 (10).ツルラン型:ツルラン(C.furcat
a)、オナガエビネ(C.longicalcarat
a)、オキナワエビネ(C.okinawaensi
s)、マスカ(C.masuca)、マダガスカリエン
シス(C.madagascariensis)、ナタ
レンシス(C.natalensis)。 (11).トクサラン型:トクサラン(C.venus
ta)、シロトクサラン(C.longipes)、ビ
ロバ(C.biloba)。 (12).ペステイタ型:ベステイタ(C.vesti
ta)、ロゼア(C.rosea)、エルメリ(C.e
lmeri)、ルベンス(C.rubens)、カージ
オグロッサ(C.cardioglossa)。
BEST MODE FOR CARRYING OUT THE INVENTION In the present invention, the following can be exemplified as Ebine of the genus Ebine of the family Orchidaceae. (1). Diebine type: diebine (C. discocol)
r), C. sieboldii, C. aristulifera, C. amamiana, C. ezine (C. iz)
u-insularis), Salmen ebine (C. tr
icarinata), Skull shrimp (C. tok)
unoshimaensis), Alisan Ebine (C.
arisanensis), Hosobanana ebine (C. gr)
aciliflora), Himalayan house lobster (C.
plantginea), chlororeuka (C. chl)
oroleuca), Togaribaebin (C. cauda)
tilabella). (2). Tin flea vine type: tin flea vine (C. li
ukiensis), Tamazaki ebine (C. dens)
iflora), Pulchra. (3). Taganelan type: Taganelan (C. bungoa)
na), Whiteana (C. whiteana). (4). Sakurajima shrimp type: Sakurajima shrimp (C.
oblanceolata), Mannii (C. mann)
i). (5). Kisoebin type: Kisoebin (C.schlec)
hteri), Alpina (C. alpina). (6). Kinseiran type: Kinseiran (C.nipp
onica). (7). Hirohanokaran type: Hirohanokaran (C. ja
ponica). (8). Asahyebine type: Asahyebine (C. hatt
orii). (9). Natsuebine type: Natsuebine (C. reflex
a). (10). Truran type: Turran (C. furcat
a), Long-tailed shrimp (C. longicarat)
a), Okinawa shrimp (C. okinawaensi)
s), masker (C. mascara), Madagascariensis, C. natalensis. (11). Toxalan type: Toxalan (C. venus)
ta), C. longipes, C. biloba. (12). Pasteta type: Vesteta (C. vesti
ta), Rosea (C. rosea), Hermerie (C. e)
lmeri), C. rubens, C. cardiolossa.

【0010】本発明の有効成分であるエビネ抽出液は、
前記エビネ属に属するエビネの少なくとも1種の花、
根、茎、葉または全草から得られる抽出エキスである。
抽出溶媒としては、低級アルキルアルコール、特に安全
性の面からエチルアルコールが望ましい。エチルアルコ
ールとしては純粋のエチルアルコールでもよいが、工業
的には含水エチルアルコールが好適である。蒸留酒のよ
うな酒精を用いることもできる。含水エチルアルコール
中のアルコール濃度は特に限定されないが、約30〜9
0%、望ましくは約40〜70%程度が実用的である。
[0010] The prawn extract, which is an active ingredient of the present invention, comprises:
At least one flower of Ebine belonging to the genus Ebine,
It is an extract obtained from roots, stems, leaves or whole plants.
As the extraction solvent, lower alkyl alcohol, particularly ethyl alcohol is desirable from the viewpoint of safety. Ethyl alcohol may be pure ethyl alcohol, but industrially, hydrated ethyl alcohol is preferred. Spirits such as distilled spirits can also be used. The alcohol concentration in the hydrated ethyl alcohol is not particularly limited, but is about 30 to 9
0%, preferably about 40-70% is practical.

【0011】本発明では、口腔用組成液のような例外的
な場合を除いて、これらのエビネ抽出液を単独で使用す
るよりも、次のような添加剤と混合して使用すること
で、その作用効果は飛躍的に向上する。添加剤として
は、ビタミン類、動植物油、グリコール酸、塩化ナトリ
ウム等があげられる。ビタミン類としては、ビタミンA
(アクセロフトール)、ビタミンB(チアミン)、ビ
タミンB(リボフラビン)、ビタミンB(ピリドキ
シン)、ビタミンC(L−アスコルビン酸)、ビタミン
E(トコフェロール)、ビタミンH(ビオチン)、ニコ
チン酸、ニコチンアミド、パントテン酸、パントテン酸
ナトリウム、パントテン酸カリウム等がある。動植物油
としては、馬油、胚芽油、卵油、オリーブ油、ツバキ
油、ナタネ油、ゴマ油等があるが、馬湯と胚芽油の組み
合わせが好適である。
In the present invention, these ebine extracts are used in a mixture with the following additives rather than used alone, except in exceptional cases such as a composition for oral cavity. The effect is greatly improved. Examples of the additives include vitamins, animal and vegetable oils, glycolic acid, sodium chloride and the like. As vitamins, vitamin A
(Accessible Roff Torr), vitamin B 1 (thiamine), vitamin B 2 (riboflavin), vitamin B 6 (pyridoxine), vitamin C (L-ascorbic acid), vitamin E (tocopherol), vitamin H (biotin), nicotinic acid Nicotinamide, pantothenic acid, sodium pantothenate and potassium pantothenate. Animal and vegetable oils include horse oil, germ oil, egg oil, olive oil, camellia oil, rapeseed oil, sesame oil, and the like, and a combination of horse bath and germ oil is preferred.

【0012】添加剤の種類及び添加量は、使用目的によ
って異なるので特定できないが、抗アレルギー組成液に
あっては、エビネ抽出液1,000mlに対して、酢酸
トコフェノールが約5〜10g、馬油が約7〜13g、
パントテン酸ナトリウムが約1〜4g、ニコチン酸アミ
ドが約1〜4g、アスコルビン酸が約5〜10g、グリ
コール酸が約0.5〜2g、ビオチンが約0.5〜1
g、ビタミンBが約0.5〜2g、塩化ナトリウムが
約12〜18gであることが望ましい。また抗アレルギ
ー性化粧用組成液にあっては、好ましくはエビネ抽出液
1,000mlに対して、酢酸トコフェノールが約6〜
12g、馬油が約4〜8g、パントテン酸ナトリウムが
約1〜4g、ニコチンアミドが約1〜3g、アスコルビ
ン酸が約8〜15g、グリコール酸が約0.5〜2g、
ビタミンBが約0.5〜2gである。また上記物質以
外であっても、通常抗アレルギー組成液や化粧料に添加
される補助的添加剤は適宜使用することができる。また
ローション、乳液、クリーム、パック、軟膏、化粧水、
浴用剤など、使用目的あるいは剤形に応じて、通常使わ
れている材料は任意に用いてもよい。
The type and amount of the additive cannot be specified because it differs depending on the purpose of use. However, in the case of the antiallergic composition solution, about 5 to 10 g of tocophenol acetate and horse About 7-13 g of oil,
About 1 to 4 g of sodium pantothenate, about 1 to 4 g of nicotinamide, about 5 to 10 g of ascorbic acid, about 0.5 to 2 g of glycolic acid, and about 0.5 to 1 g of biotin
g, vitamin B 6 is approximately 0.5 to 2 g, desirably sodium chloride is about 12~18G. In addition, in the antiallergic cosmetic composition solution, preferably, about 1,000 to 1,000 ml of tocophenol acetate is used for 1,000 ml of the shrimp extract.
12g, horse oil about 4-8g, sodium pantothenate about 1-4g, nicotinamide about 1-3g, ascorbic acid about 8-15g, glycolic acid about 0.5-2g,
Vitamin B 6 is about 0.5~2g. In addition to the above substances, auxiliary additives usually added to antiallergic composition liquids and cosmetics can be appropriately used. Also lotions, emulsions, creams, packs, ointments, lotions,
Materials commonly used, such as bath agents, may be optionally used depending on the purpose of use or dosage form.

【0013】エビネ抽出液と添加剤組成液の混合比は、
使用目的に応じて異なるので特定できないが、抗アレル
ギー用組成液にあっては、エビネ抽出液が全体の10〜
20容量%、抗アレルギー性化粧液にあっては5〜10
%が好適である。
The mixing ratio of the shrimp extract and the additive composition solution is as follows:
Although it cannot be specified because it differs depending on the purpose of use, in the composition solution for anti-allergy, the shrimp extract
20% by volume, 5 to 10 for antiallergic lotion
% Is preferred.

【0014】エビネ抽出液の製造は、たとえば次のごと
く行う。エビネの地下茎などに付着した泥を落とし、全
草を水洗する。次いで、カッター、ミキサーなどで細片
にして、プレスにより圧縮搾汁する。プレスの圧縮圧力
は、500〜5,000kg/cm程度で行う。搾汁
液に対して20〜90%の含水エチルアルコールを約
1:1(容量)の割合で混合する。使用目的によって
は、例えば抗アレルギー性化粧料のような場合、香りの
高いエビネの花のみを前記同様の方法で処理して、抽出
液を得ることが望ましい。また、前記同様に泥を落とし
水洗したエビネの全草をカッターで細切りしたのちミキ
サーですりつぶし、タンク内でエビネ約10,000g
に対して約20〜90%エチルアルコール約20,00
0mlを混合、7〜10日間冷暗所において密閉保存し
た後、固液分離し濾過してもよい。これらの抽出液は、
約1〜2週間冷暗所で密封熟成することにより、さらに
効果的になる。
The production of the shrimp extract is carried out, for example, as follows. Remove mud adhering to the rhizomes of Ebine and wash the whole plant with water. Next, the pieces are cut into small pieces with a cutter, a mixer or the like, and compressed and squeezed with a press. The pressing pressure of the press is about 500 to 5,000 kg / cm 2 . 20-90% aqueous ethyl alcohol is mixed in the juice at a ratio of about 1: 1 (volume). Depending on the purpose of use, for example, in the case of an anti-allergic cosmetic, it is desirable to treat only fragrant Ebine flowers in the same manner as described above to obtain an extract. In the same manner as described above, the whole grass of the ebine that had been dropped and washed with water was cut into small pieces with a cutter, and then ground with a mixer.
About 20-90% ethyl alcohol about 20,000
0 ml may be mixed and stored tightly in a cool dark place for 7 to 10 days, followed by solid-liquid separation and filtration. These extracts are
Aged for about 1-2 weeks in a cool, dark place for further aging.

【0015】エビネ抽出液と他の添加剤との混合は、ビ
タミン類には水溶性のものもあれば油溶性のものもあ
り、使用動植物油との関係も含めて、溶媒には水、温
水、エチルアルコールまたはそれらの混合液を用い、大
略後述する実施例に準ずるのが望ましい。操作として
は、加温は原則的に湯煎で行い、要すれば攪拌する。
The mixture of the shrimp extract and other additives may be water-soluble or oil-soluble for vitamins, and the solvent may be water or hot water, including the relationship with the animal and vegetable oils used. , Ethyl alcohol or a mixed solution thereof, and it is preferable to substantially follow the examples described later. As an operation, heating is performed in principle with hot water and stirring if necessary.

【0016】各添加剤の作用は、必ずしも明確ではない
が、一般的にビタミン類は粘膜、神経の保健に役立ち、
皮膚の角質化の防止機能がある。ビタミンB、ビタミ
ンB皮膚、粘膜の神経を安定化させるとともに活性化
し、細胞呼吸を助ける。ビタミンCは皮膚の新陳代謝を
促し、ビタミンEは血行促進、細胞活性化作用がある。
ビタミンH、ニコチン酸、ニコチンアミド、パントテン
酸とその塩類は、いずれも代謝機能を改善し、ビオチン
は皮膚疾患の予防作用がある。動植物油は皮膚をやわら
かくし、特に馬湯と胚芽油は効果的である。グリコール
酸はpH調製のために使用し、塩化ナトリウムはその浸
透圧的な作用により、抽出物が皮膚の深部まで吸収され
やすくなる。
The action of each additive is not always clear, but vitamins generally help mucous membrane and nerve health,
It has the function of preventing keratinization of the skin. Vitamin B 1 , Vitamin B 2 Stabilizes and activates nerves on the skin and mucous membranes and helps cell respiration. Vitamin C promotes skin metabolism, and vitamin E promotes blood circulation and activates cells.
Vitamin H, nicotinic acid, nicotinamide, pantothenic acid and salts thereof all improve metabolic functions, and biotin has a protective effect on skin diseases. Animal and vegetable oils soften the skin, and Mabyu and germ oil are particularly effective. Glycolic acid is used for pH adjustment, and sodium chloride, due to its osmotic action, makes it easier for the extract to be absorbed deep into the skin.

【0017】[0017]

【実施例1】 (1).エビネ抽出液の調製:原料として宮崎県の山野
に自生するジエビネを用いた。まずエビネの地下茎など
に付着した泥を落とし、全草を水洗した。次いで、ミキ
サーで砕片にした。砕片10,000gをプレスにより
圧縮搾汁し、搾汁液を得た。プレスの圧縮圧力は1,0
00kg/cmであった。搾汁液に対して70%の含
水エチルアルコールを約20,000ml加えて、冷暗
所で10日間熟成した。熟成後、固液分離して濾過し、
エビネ抽出液を得た。 (2).添加剤組成液の調製:エビネ抽出液1,000
mlに対して、各成分を個別的に下記の工程で調製し
た。 .精製水453mlと99%エチルアルコールを用意
した。精製水のみは、湯煎にかけ加温しておいた。 .容器に酢酸トコフェノール7.3gを入れ、99%
エチルアルコール250mlを加え、70℃の湯煎にか
けて溶かした。次いで胚芽油7g加えた。 .容器に馬油10.3gを入れ、99%エチルアルコ
ール247mlを加え、70℃の湯煎にかけて溶かし
た。 .容器に加温精製水100mlを入れ、パントテン酸
ナトリウム2.3gとニコチン酸アミド2.3gを加え
て攪拌した。 .容器に加温精製水120mlを入れ、アスコルビン
酸7.7gとグリコール酸1gを加えて攪拌した。 .容器に精製水70mlと99%エチルアルコール5
0mlを入れ、ビオチン0.8gを加えて、70℃の湯
煎にかけ、透明になるまで溶かした。 .容器に加温精製水50mlを入れ、1gのビタミン
を加え攪拌した。 .容器に加温精製水113mlをいれ、塩化ナトリウ
ム15.4g加えて攪拌した。 .容器にの溶液を入れ、これにの溶液を加え、
残りをこの順で加えて混合液を得た。この混合
液にを加えて1,000mlとした。1,000ml
の混合液を2週間熟成した。 (3).抗アレルギー組成液の調製:(1)のエビネ抽
出液を精製水で2倍に希釈して、(2)の添加剤組成液
に加えた。エビネ抽出液と添加剤組成液は1:1の割合
で混合、エビネ抽出液の割合が15容量%(1,000
ml中150ml)となるように調製した。
Embodiment 1 (1). Preparation of Ebine extract: Diebine native to Yamano, Miyazaki Prefecture was used as a raw material. First, mud attached to the rhizomes of shrimp was dropped, and the whole plant was washed with water. Then, it was crushed with a mixer. 10,000 g of crushed pieces were compressed and squeezed by a press to obtain a squeezed liquid. Press compression pressure is 1,0
It was 00 kg / cm 2 . About 20,000 ml of 70% aqueous ethyl alcohol was added to the squeezed liquid, and the mixture was aged in a cool and dark place for 10 days. After aging, solid-liquid separation and filtration,
Ebine extract was obtained. (2). Preparation of additive composition liquid: Shrimp extract 1,000
For each ml, each component was individually prepared by the following steps. . 453 ml of purified water and 99% ethyl alcohol were prepared. Only purified water was heated in hot water. . Put 7.3 g of tocophenol acetate in a container,
Ethyl alcohol (250 ml) was added, and the mixture was dissolved in a water bath at 70 ° C. Then, 7 g of germ oil was added. . 10.3 g of horse oil was put in a container, 247 ml of 99% ethyl alcohol was added, and the mixture was dissolved in a 70 ° C water bath. . 100 ml of heated purified water was put in a container, 2.3 g of sodium pantothenate and 2.3 g of nicotinamide were added, and the mixture was stirred. . 120 ml of heated purified water was put in a container, 7.7 g of ascorbic acid and 1 g of glycolic acid were added and stirred. . 70 ml of purified water and 99% ethyl alcohol 5 in a container
0 ml was added, and 0.8 g of biotin was added. The mixture was immersed in water at 70 ° C. and dissolved until it became transparent. . Put warm purified water 50ml, it was added to the kettle and stirred added vitamin B 6 of 1g. . 113 ml of heated purified water was put in a container, and 15.4 g of sodium chloride was added and stirred. . Put the solution in the container, add the solution to this,
The remainder was added in this order to obtain a mixture. The mixture was added to make up to 1,000 ml. 1,000ml
Was aged for 2 weeks. (3). Preparation of antiallergic composition liquid: The shrimp extract of (1) was diluted twice with purified water and added to the additive composition liquid of (2). The shrimp extract and the additive composition solution were mixed at a ratio of 1: 1. The shrimp extract had a ratio of 15% by volume (1,000%).
(150 ml per ml).

【0018】[0018]

【対照例1】実施例1からエビネ抽出液のみを除き、そ
の他は実施例1と同一の工程で同一の組成に調製した組
成液を得た。
COMPARATIVE EXAMPLE 1 A composition liquid having the same composition as in Example 1 was prepared in the same manner as in Example 1 except that only the shrimp extract was used.

【0019】[0019]

【治験例1】実施例1と対照例1の組成液をアトピー性
皮膚炎の患部に1日2回、直接塗布した。治験者は各4
0人で、内各20人はアトピー症状が発症して1〜5年
以内(病歴A群)の患者、残り各20人は6〜15年
(病歴B群)の患者であった。治験期間は、最高6ヶ月
であった。結果を表1に示す。
[Trial Example 1] The compositions of Example 1 and Control Example 1 were directly applied twice a day to the affected part of atopic dermatitis. Investigators are 4 each
Of the 0 patients, 20 of each were patients within 1 to 5 years of onset of atopic symptoms (medical history group A), and the remaining 20 were 6 to 15 years (medical history group B). The study period was up to 6 months. Table 1 shows the results.

【0020】[0020]

【表1】 [Table 1]

【0021】[0021]

【実施例2】 (1).エビネ抽出液の調製:原料にニオイエビネの花
のみを使用した以外は、実施例1と同じ方法でエビネ抽
出液を得た。 (2).添加剤組成液の調製:この花エビネ抽出液1,
000mlに対して、下記の成分を実施例1と同じ方法
で個別的に調製した。 .精製水900ml 99%エチルアルコール100ml .胚芽油 4.0g 酢酸トコフェロール 8.5g 99%エチルアルコール 50.0ml .馬油 6.0g 99%エチルアルコール 50.0ml .パントテン酸ナトリウム 2.5g ニコチンアミド 1.8g 精製水 400.0ml .アスコルビン酸 11.4g グリコール酸 1.0g 精製水 400.0ml .ビタミンB6 1.0g 精製水 100.0ml .容器にの溶液を入れ、残りをこの順で加
えて混合液を得た。この混合液にを加えて1,000
mlとした。1,000mlの混合液を2週間熟成し
た。 (3).抗アレルギー性組成液の調製:(1)の花エビ
ネ抽出液と(2)の添加剤組成液を1:2の割合で混合
し、混合液中の花エビネ抽出液の割合が7容量%(1,
000ml中70ml)になるように調製した。得られ
た化粧水は、エビネの花のみを原料とした。この化粧水
を6ヶ月間、40人の治験者(女性のみ)の手及び顔に
1日に朝晩各1回つけてもらった。その結果、治験例1
と略同様の抗アレルギー効果が得られた。加えて、肌の
かさつきがなくなり、うるおいとつやがで、香りもよ
く、抗アレルギー性化粧料としても好適であった。
Embodiment 2 (1). Preparation of Ebine extract: An Ebine extract was obtained in the same manner as in Example 1 except that only the flower of the odorant was used as a raw material. (2). Preparation of additive composition solution: This flower shrimp extract 1,
For 000 ml, the following components were individually prepared in the same manner as in Example 1. . 900 ml of purified water 100 ml of 99% ethyl alcohol Germ oil 4.0 g Tocopherol acetate 8.5 g 99% ethyl alcohol 50.0 ml. Horse oil 6.0 g 99% ethyl alcohol 50.0 ml. Sodium pantothenate 2.5 g Nicotinamide 1.8 g Purified water 400.0 ml. Ascorbic acid 11.4 g Glycolic acid 1.0 g Purified water 400.0 ml. Vitamin B6 1.0 g Purified water 100.0 ml. The solution was put in a container, and the rest was added in this order to obtain a mixed solution. Add this mixture to 1,000
ml. 1,000 ml of the mixture was aged for 2 weeks. (3). Preparation of anti-allergic composition solution: (1) the flower shrimp extract solution and the additive composition solution of (2) are mixed at a ratio of 1: 2, and the ratio of the flower shrimp extract solution in the mixture is 7% by volume ( 1,
(70 ml in 000 ml). The obtained lotion was made from only ebine flowers. The lotion was applied to the hands and faces of 40 test subjects (female only) once every morning and evening for 6 months. As a result, Trial Example 1
Almost the same anti-allergic effect was obtained. In addition, there was no bulkiness on the skin, the skin was moist and shiny, the fragrance was good, and it was suitable as an antiallergic cosmetic.

【0022】[0022]

【安全性試験】エビネ全草抽出エキスの安全性に関する
試験として、医薬品毒性試験法ガイドライン(平成5年
8月10日付薬新薬第88号「単回及び反復投与毒性試
験ガイドラインの改正について」)に基づき、エビネ全
草抽出エキスを雌雄ラットに1回経口投与した。この試
験は、昭和57年3月31日付薬発313号「医薬品の
安全性試験の実施に関する基準について」およびその改
正基準に従って実施した。試験方法及び結果は下記の通
りである。 (1).被験物質:製造後1年以上経過し、安定したエ
ビネ全草抽出エキス。 (2).対照物質:注射用水(株式会社大塚製薬製)。 (3).使用動物:Crj:CD(SD)系の雌雄ラッ
ト(SPF)。4週齢の雌雄各14匹。体重雄77〜8
6g、雌68〜77gであった。 (4).投与方法:前記エビネ全草抽出エキスをラット
に注射筒を用いて強制的に経口投与した。投与液量は投
与日の体重を基準とし、2ml/gで算出した。投与回
数は1日1回、午前10時頃に投与、14日間継続し
た。 (5).観測及び検査方法と結果: .一般状態は、投与日は投与前及び投与後、翌日から
は1日1回観察したが、表2に示すように、雌雄いずれ
の群からも異常は認められなかった。 .体重測定:体重は、投与日及び投与後1日、3日、
7日、10日、14日に測定した。その結果、表3及び
表4に示すように、雌雄いずれの群も対照群とほぼ同様
の推移を示し、体重にも有意差は認められなかった。有
意差検定は、各群で平均値及び標準偏差を算出し、分散
の同等性をP検定で確認した後、分散が等しい場合は、
Studentのt検定を用いて、対照群と被験物質投
与群との間で行った。有意水準は危険率5%未満(p<
0.05)とした。 .剖験:観測終了時に全例をエーテル麻酔下で腹大動
脈から放血致死させた後に剖験したが、表5に示すよう
に、雌雄いずれの群にも異常は認められなかった。以上
の結果、安全性試験の上限量として通常用いられる2,
000g/kgにおいても、雌雄ともに死亡例は認めら
れず、体重推移、剖験のいずれにおいてもエビネ全草抽
出エキス投与による影響は認められなかったので、エビ
ネ抽出エキスは、毒性がなく安全であると推定される。
[Safety test] As a test on the safety of Ebine whole plant extract, it is included in the guidelines on drug toxicity test method (Revision of Single and Repeated Dose Toxicity Test Guideline for Drug Shinyaku No. 88, August 10, 1993). Based on the above, the extract of Ebine whole plant was orally administered once to male and female rats. This test was carried out in accordance with Yakuhin 313, March 31, 1982, “Standards for Conducting Safety Tests for Drugs” and its revised standards. The test method and results are as follows. (1). Test substance: Ebine whole plant extract that has been stable for more than one year after production. (2). Control substance: water for injection (Otsuka Pharmaceutical Co., Ltd.). (3). Animals used: Crj: CD (SD) male and female rats (SPF). Fourteen-week old males and females fourteen. Male weight 77-8
6 g, female 68-77 g. (4). Administration method: The above-mentioned whole plant extract of Ebine was forcibly administered orally to rats using a syringe. The dose was calculated at 2 ml / g based on the body weight on the day of administration. The administration was performed once a day at about 10 am and continued for 14 days. (5). Observation and inspection methods and results: The general condition was observed before and after the administration on the day of administration, and once a day from the next day. As shown in Table 2, no abnormality was observed in any of the male and female groups. . Body weight measurement: Body weight was measured on the day of administration and 1 day after administration, 3 days,
Measurements were taken on days 7, 10, and 14. As a result, as shown in Tables 3 and 4, both male and female groups showed almost the same transition as the control group, and no significant difference was observed in the body weight. In the significance test, the average value and the standard deviation are calculated in each group, and after confirming the equivalence of the variance by the P test, if the variances are equal,
Using the Student's t test, the test was performed between the control group and the test substance administration group. The significance level is less than 5% (p <
0.05). . Necropsy: At the end of the observation, all the animals were killed by exsanguination from the abdominal aorta under ether anesthesia under ether anesthesia. Necropsy was performed. As shown in Table 5, no abnormalities were observed in any of the male and female groups. As a result, 2, which is usually used as the upper limit of the safety test,
Even at 000 g / kg, no mortality was observed in both sexes, and no effect was observed in the body weight change or necropsy due to the administration of Ebine whole plant extract. Therefore, the Ebine extract is safe without toxicity. It is estimated to be.

【0023】[0023]

【表2】 [Table 2]

【0024】[0024]

【表3】 [Table 3]

【0025】[0025]

【表4】 注:表3,表4におけるTT=Analysis of
Student’st−test
[Table 4] Note: TT in Tables 3 and 4 = Analysis of
Student's-test

【0026】[0026]

【表5】 [Table 5]

【0027】[0027]

【ヒト皮膚一時刺激性試験】エビネ全草抽出エキスの安
全性に関する試験として、クローズドバッチによるヒト
皮膚一時刺激性試験を下記の通り実施した。 (1).被験物質:エビネ全草抽出エキス(8.8%含
有)。原体、無調整、室温保存。 (2).対照物質:バッチテスト用絆創膏(リバーテー
プ株式会社製)円形布地部(ブランク) (3).試験系:ヒト皮膚 (4).試験方法:男女計20人(うち男子12人、女
子8人)の被験者を対象にして、被験物質(エビネ全草
抽出エキス)0.1mlを上腕部皮膚面に接着し、その
上からヒトバッチテスト用絆創膏(リバーテープ株式会
社製)にて固定した。さらにブランク対照としてバッチ
テスト用絆創膏円形布地部を上記被験物質に並列して同
皮膚面に接着した。48時間後に絆創膏を取り除き、被
験物質及び対照負荷部の皮膚症状を肉眼的に観察、評価
した。被験物質負荷部の皮膚所見については、刺激症状
の有無(紅斑、浮腫、水痘)を確認し、日本バッチテス
ト研究会の基準により判定した。 (5).試験結果:被験物質のヒト皮膚に対する48時
間のクローズドバッチテストの結果は、絆創膏の除去直
後において刺激性反応は全く認められなかった。したが
って、被験物質は無刺激性と評価される。
[Temporary irritation test on human skin] As a test on the safety of the extract of the whole plant extract of Ebine, a temporary irritation test on human skin using a closed batch was carried out as follows. (1). Test substance: Ebine whole plant extract (containing 8.8%). API, unadjusted, stored at room temperature. (2). Control substance: bandage for batch test (manufactured by River Tape Co., Ltd.) circular fabric part (blank) (3). Test system: human skin (4). Test method: For a total of 20 male and female subjects (including 12 males and 8 females), 0.1 ml of test substance (Ebine whole plant extract) was adhered to the upper arm skin surface, and a human batch was placed thereon. It was fixed with a test plaster (manufactured by River Tape Co., Ltd.). Further, as a blank control, a circular bandage of a bandage for a batch test was adhered to the skin surface in parallel with the test substance. After 48 hours, the bandage was removed, and the skin symptoms of the test substance and the control loading area were visually observed and evaluated. Regarding the skin findings of the test substance-loaded part, the presence or absence of irritation symptoms (erythema, edema, chickenpox) was confirmed, and judged according to the criteria of the Japan Batch Test Study Group. (5). Test results: The results of the 48-hour closed batch test of the test substance on human skin showed that no irritative reaction was observed immediately after the bandage was removed. Therefore, the test substance is evaluated as non-irritant.

【0029】[0029]

【表6】 [Table 6]

【0030】[0030]

【発明の効果】本発明によるエビネ抽出液を有効成分と
する皮膚外用組成物によれば、しかも毒性がないので、
家庭内で長期にわたり外用薬、化粧料、浴用剤として安
全に使用できる。特に.アレルギー性疾患、たとえば発
赤、湿疹、蕁麻疹、浮腫、腫脹、なかでもアトピー性皮
膚炎の治療に顕著な効果がある。また、これに加えて、
肌荒れ、かさつき、肌の肌理を改善し、肌にうるおいと
つやを与え、肌の老化防止にも役立つなど、スキンケア
の効果がある。
EFFECTS OF THE INVENTION According to the composition for external use on skin comprising the shrimp extract according to the present invention as an active ingredient, and because it has no toxicity,
It can be safely used as a topical medicine, cosmetic, or bath agent for a long time at home. Especially. It has a remarkable effect in the treatment of allergic diseases such as redness, eczema, hives, edema, swelling, and especially atopic dermatitis. In addition to this,
It has skin care effects such as improving rough skin, roughening, texture of skin, giving skin moisture and luster, and preventing skin aging.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI A61K 31/19 A61K 31/19 31/355 ABF 31/355 ABF 31/375 31/375 31/415 31/415 31/44 31/44 31/455 31/455 33/14 33/14 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification code FI A61K 31/19 A61K 31/19 31/355 ABF 31/355 ABF 31/375 31/375 31/415 31/415 31/44 31 / 44 31/455 31/455 33/14 33/14

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 ラン科植物のエビネ属に属するエビネの
少なくとも1種からの抽出物を有効成分として含むこと
を特徴とする抗アレルギー性皮膚外用組成物。
1. An antiallergic skin external composition comprising, as an active ingredient, an extract from at least one species of Ebine belonging to the genus Ebine of the orchid family.
【請求項2】 エビネ抽出物に加えて、ビタミン類、動
植物油、グリコール酸、塩化ナトリウムを含むことを特
徴とする請求項1記載の抗アレルギー性皮膚外用組成
物。
2. The antiallergic external skin composition according to claim 1, further comprising vitamins, animal and vegetable oils, glycolic acid, and sodium chloride in addition to the shrimp extract.
【請求項3】 ビタミン類がパントテン酸ナトリウム、
ニコチンアミド、酢酸トコフェロール、アスコルビン
酸、ビオチン、ビタミンBであり、動植物油が胚芽油
と馬油であることを特徴とする請求項2記載の抗アレル
ギー性皮膚外用組成物。
3. The method according to claim 1, wherein the vitamins are sodium pantothenate,
Nicotinamide, tocopherol acetate, ascorbic acid, biotin, a vitamin B 6, anti-allergic skin external composition according to claim 2, wherein the animal or vegetable oil is germ oil and horse oil.
JP33264296A 1996-11-07 1996-11-07 Anti-allergic skin external composition Expired - Lifetime JP3702307B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP33264296A JP3702307B2 (en) 1996-11-07 1996-11-07 Anti-allergic skin external composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33264296A JP3702307B2 (en) 1996-11-07 1996-11-07 Anti-allergic skin external composition

Publications (2)

Publication Number Publication Date
JPH10139676A true JPH10139676A (en) 1998-05-26
JP3702307B2 JP3702307B2 (en) 2005-10-05

Family

ID=18257246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP33264296A Expired - Lifetime JP3702307B2 (en) 1996-11-07 1996-11-07 Anti-allergic skin external composition

Country Status (1)

Country Link
JP (1) JP3702307B2 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11193211A (en) * 1997-05-10 1999-07-21 Nomura:Kk Cosmetic
JP2000016922A (en) * 1998-06-26 2000-01-18 Nomura:Kk Hair tonic
WO2000012059A1 (en) * 1998-08-27 2000-03-09 The Procter & Gamble Company Methods of reducing the irritation associated with vitamin b3 compositions
JP2000128729A (en) * 1998-10-20 2000-05-09 Joji Yamahara Cosmetic
WO2000027224A1 (en) * 1998-11-11 2000-05-18 Manabu Nomura Health-promoting foods
US6224888B1 (en) 1999-02-12 2001-05-01 The Procter & Gamble Company Cosmetic compositions
US6309657B2 (en) 1999-02-12 2001-10-30 The Procter & Gamble Company Cosmetic compositions
US6444647B1 (en) 1999-04-19 2002-09-03 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US6455055B1 (en) 1999-02-12 2002-09-24 The Procter & Gamble Company Cosmetic compositions
JP2013123450A (en) * 2011-12-13 2013-06-24 Akihiro Sato Medical treatment method of pneumoconiosis to which metal complex ion liquid is applied, and medical treatment method of pharynx, trachea and bronchus
KR101464745B1 (en) * 2008-01-29 2014-11-24 주식회사 엘지생활건강 Compositions comprising fermentative extract of Orchidaceae for improving functions of skin
JP2015214520A (en) * 2014-05-13 2015-12-03 株式会社ノムラ Calanthe discolor extract

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05294813A (en) * 1992-02-17 1993-11-09 Manabu Nomura Hair producing and hair growing agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05294813A (en) * 1992-02-17 1993-11-09 Manabu Nomura Hair producing and hair growing agent

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11193211A (en) * 1997-05-10 1999-07-21 Nomura:Kk Cosmetic
JP2000016922A (en) * 1998-06-26 2000-01-18 Nomura:Kk Hair tonic
WO2000012059A1 (en) * 1998-08-27 2000-03-09 The Procter & Gamble Company Methods of reducing the irritation associated with vitamin b3 compositions
JP2000128729A (en) * 1998-10-20 2000-05-09 Joji Yamahara Cosmetic
WO2000027224A1 (en) * 1998-11-11 2000-05-18 Manabu Nomura Health-promoting foods
US6309657B2 (en) 1999-02-12 2001-10-30 The Procter & Gamble Company Cosmetic compositions
US6224888B1 (en) 1999-02-12 2001-05-01 The Procter & Gamble Company Cosmetic compositions
US6455055B1 (en) 1999-02-12 2002-09-24 The Procter & Gamble Company Cosmetic compositions
US6528071B2 (en) 1999-02-12 2003-03-04 The Procter & Gamble Company Cosmetic compositions
US6444647B1 (en) 1999-04-19 2002-09-03 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
KR101464745B1 (en) * 2008-01-29 2014-11-24 주식회사 엘지생활건강 Compositions comprising fermentative extract of Orchidaceae for improving functions of skin
JP2013123450A (en) * 2011-12-13 2013-06-24 Akihiro Sato Medical treatment method of pneumoconiosis to which metal complex ion liquid is applied, and medical treatment method of pharynx, trachea and bronchus
JP2015214520A (en) * 2014-05-13 2015-12-03 株式会社ノムラ Calanthe discolor extract

Also Published As

Publication number Publication date
JP3702307B2 (en) 2005-10-05

Similar Documents

Publication Publication Date Title
US10195239B2 (en) Extract of Trigonella foenum-graecum
HU202743B (en) Active ingredient composition comprising medicinal herb extracts, cosmetics comprising such active ingredient and process for producing medicinal and veterinary compositions
KR20110082292A (en) Antipuritis and antiance effects of dendropanax morbifera lev. extract
JP3702307B2 (en) Anti-allergic skin external composition
CN108938501A (en) Chinese medicine composition and oral care product applied to oral care product
US8455007B2 (en) Method to treat propolis
JPH09208484A (en) Active oxygen-eliminator and composition containing the same
JPH11322627A (en) Antiallergic external composition for skin
KR101874830B1 (en) Antibacterial Cosmetics Composition
KR101869763B1 (en) Composition for preventing and curing dermatophytosis
RU2607931C2 (en) Therapeutic composition for oral care for hematology-oncology patients
CN108619486B (en) Ointment for treating skin diseases and preparation method thereof
JP3513475B2 (en) Hair growth / hair restorer
KR101833025B1 (en) Composition for protecting and treating acne comprising Siegesbeckia pubescens
JPH0310609B2 (en)
JPS5913726A (en) Food composed mainly of concentrated dropwort
WO2007144723A2 (en) Use of plants of carpobrotus edulis as anti-itching and/or anti-inflammatory agents
JP2005179219A (en) Skin care preparation for external use
JPH08133983A (en) Extract of aspalathus linealis and its use
RU2799443C2 (en) Hair and scalp cleaner and care
JP2005015375A (en) External preparation for skin, characterized by containing exocrine polysaccharide obtained from alteromonas macleodii
JP6590233B1 (en) Skin disease therapeutic agent and method for producing the same
KR20110058753A (en) Composition for improving condition of hair and scalp containing plant extracts
KR20110058754A (en) Composition for improving condition of hair and scalp containing plant extracts
RU2131741C1 (en) Species possessing antidiabetic action &#34;chelek&#34;

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050201

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050404

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20050510

R155 Notification before disposition of declining of application

Free format text: JAPANESE INTERMEDIATE CODE: R155

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090729

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100729

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110729

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120729

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130729

Year of fee payment: 8

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term